header
Image from OpenLibrary

The relationship between conjugated linoleic acid and insulin resistance in type 2 diabetes / Hanan Galal Hassan Haridy ; Supervised Omar Elsadany , Mona Abdelmonem Hegazy , Laila Ahmed Rashed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Hanan Galal Hassan Haridy , 2017Description: 137 P. : facsimiles ; 25cmOther title:
  • العلاقة بين حمض اللينوليك ومقاومة الإنسولين فى مرضى السكرى من النوع الثانى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine Summary: Background: The relationship between obesity, insulin resistance and type 2 diabetes has fundamental clinical implications. Nonalcoholic fatty liver disease is one of the most common complications in diabetic patients with variable grades ranging from grade I to grade IV hepatic steatosis. Low CLA is a consequence of the presence of obesity and insulin resistance (HOMA-IR) in diabetic patients. Objectives: Assessing the link between CLA and HOMA-IR in type 2 diabetic patients with variable values of BMI and also with variable grades of hepatic steatosis diagnosed by abdominal ultrasonography. Methods: The study was conducted on 50 type 2 diabetic patients with variable BMI values and variable grades of NAFLD diagnosed by abdominal ultrasound. The patients were subjected to anthropometric measures, total lipid profile, serum CLA, fasting blood glucose, fasting insulin level, liver enzymes (ALT and AST), and calculation of HOMA-IR. Results: There were a significant difference between diabetic patients and normal control participants regarding anthropometric measurements, liver enzymes (ALT and AST), fasting blood sugar, fasting insulin level and total lipid profile. HOMA-IR was higher in diabetic patients with high BMI and grade IV hepatic steatosis. Low levels of CLA were recorded in diabetic obese patients with grade III and grade IV hepatic steatosis when compared with diabetic obese patients with both grades I and II hepatic steatosis
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2017.Ha.R (Browse shelf(Opens below)) Not for loan 01010110074511000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2017.Ha.R (Browse shelf(Opens below)) 74511.CD Not for loan 01020110074511000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine

Background: The relationship between obesity, insulin resistance and type 2 diabetes has fundamental clinical implications. Nonalcoholic fatty liver disease is one of the most common complications in diabetic patients with variable grades ranging from grade I to grade IV hepatic steatosis. Low CLA is a consequence of the presence of obesity and insulin resistance (HOMA-IR) in diabetic patients. Objectives: Assessing the link between CLA and HOMA-IR in type 2 diabetic patients with variable values of BMI and also with variable grades of hepatic steatosis diagnosed by abdominal ultrasonography. Methods: The study was conducted on 50 type 2 diabetic patients with variable BMI values and variable grades of NAFLD diagnosed by abdominal ultrasound. The patients were subjected to anthropometric measures, total lipid profile, serum CLA, fasting blood glucose, fasting insulin level, liver enzymes (ALT and AST), and calculation of HOMA-IR. Results: There were a significant difference between diabetic patients and normal control participants regarding anthropometric measurements, liver enzymes (ALT and AST), fasting blood sugar, fasting insulin level and total lipid profile. HOMA-IR was higher in diabetic patients with high BMI and grade IV hepatic steatosis. Low levels of CLA were recorded in diabetic obese patients with grade III and grade IV hepatic steatosis when compared with diabetic obese patients with both grades I and II hepatic steatosis

Issued also as CD

There are no comments on this title.

to post a comment.